{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:18:44Z","timestamp":1740122324343,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-024-10422-w","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T02:01:35Z","timestamp":1721181695000},"page":"1107-1116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extended thromboprophylaxis in heart failure patients; the unmet need"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-8407","authenticated-orcid":false,"given":"Majed S.","family":"Al Yami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmajeed M.","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed M.","family":"Alay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmalik Y.","family":"Aljoufi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam S.","family":"Alsulimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shatha M.","family":"Algarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumaya N.","family":"Almohareb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awatif M.","family":"Hafiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar A.","family":"Alshaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal M.","family":"Badawoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"10422_CR1","doi-asserted-by":"publisher","unstructured":"Benjamin EJ, Virani SS, Callaway CW et al (2018) Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association [published correction appears in Circulation. 2018 Mar 20;137(12):e493.\u00a0https:\/\/doi.org\/10.1161\/CIR.0000000000000573. Circulation. 137(12):e67\u2013e492.\u00a0https:\/\/doi.org\/10.1161\/CIR.0000000000000558","DOI":"10.1161\/CIR.0000000000000573 10.1161\/CIR.0000000000000558"},{"issue":"2","key":"10422_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jacc.2019.11.028","volume":"75","author":"SZ Goldhaber","year":"2020","unstructured":"Goldhaber SZ (2020) Venous thromboembolism in heart failure patients: pathophysiology, predictability,\u00a0prevention. J Am Coll Cardiol 75(2):159\u2013162. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.028","journal-title":"J Am Coll Cardiol"},{"issue":"23 Suppl 1","key":"10422_CR3","doi-asserted-by":"publisher","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","volume":"107","author":"FA Anderson","year":"2003","unstructured":"Anderson FA, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9-16. https:\/\/doi.org\/10.1161\/01.CIR.0000078469.07362.E6","journal-title":"Circulation"},{"issue":"17","key":"10422_CR4","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1161\/CIRCULATIONAHA.111.084467","volume":"125","author":"MAM Rogers","year":"2012","unstructured":"Rogers MAM, Levine DA, Blumberg N, Flanders SA, Chopra V, Langa KM (2012) Triggers of hospitalization for venous thromboembolism. Circulation 125(17):2092\u20132099. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.084467","journal-title":"Circulation"},{"issue":"11","key":"10422_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.amjmed.2008.05.045","volume":"121","author":"R Alikhan","year":"2008","unstructured":"Alikhan R, Spyropoulos AC (2008) Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease. Am J Med 121(11):935\u2013942. https:\/\/doi.org\/10.1016\/j.amjmed.2008.05.045","journal-title":"Am J Med"},{"issue":"7","key":"10422_CR6","doi-asserted-by":"publisher","first-page":"e045672","DOI":"10.1136\/bmjopen-2020-045672","volume":"11","author":"A Pandor","year":"2021","unstructured":"Pandor A, Tonkins M, Goodacre S et al (2021) Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review. BMJ Open 11(7):e045672. https:\/\/doi.org\/10.1136\/bmjopen-2020-045672","journal-title":"BMJ Open"},{"issue":"20","key":"10422_CR7","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1182\/blood.2019003603","volume":"135","author":"AJ Darzi","year":"2020","unstructured":"Darzi AJ, Karam SG, Charide R et al (2020) Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis. Blood 135(20):1788\u20131810. https:\/\/doi.org\/10.1182\/blood.2019003603","journal-title":"Blood"},{"issue":"04","key":"10422_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1160\/TH16-08-0631","volume":"117","author":"A Stuck","year":"2017","unstructured":"Stuck A, Spirk D, Schaudt J, Kucher N (2017) Risk assessment models for venous thromboembolism in acutely ill medical patients. Thromb Haemost 117(04):801\u2013808. https:\/\/doi.org\/10.1160\/TH16-08-0631","journal-title":"Thromb Haemost"},{"issue":"2","key":"10422_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/jth.15607","volume":"20","author":"G Forgo","year":"2022","unstructured":"Forgo G, Micieli E, Ageno W et al (2022) An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the world thrombosis day steering committee: systematic review and meta-analysis. J Thromb Haemost 20(2):409\u2013421. https:\/\/doi.org\/10.1111\/jth.15607","journal-title":"J Thromb Haemost"},{"issue":"7537","key":"10422_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","volume":"332","author":"AT Cohen","year":"2006","unstructured":"Cohen AT, Davidson BL, Gallus AS et al (2006) Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 332(7537):325\u2013329. https:\/\/doi.org\/10.1136\/bmj.38733.466748.7C","journal-title":"BMJ"},{"issue":"2","key":"10422_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1358863X07079017","volume":"12","author":"AT Cohen","year":"2007","unstructured":"Cohen AT, Turpie AGG, Leizorovicz A et al (2007) Thromboprophylaxis with dalteparin in medical patients: which patients benefit? Vasc Med 12(2):123\u2013127. https:\/\/doi.org\/10.1177\/1358863X07079017","journal-title":"Vasc Med"},{"issue":"22","key":"10422_CR12","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","volume":"2","author":"HJ Sch\u00fcnemann","year":"2018","unstructured":"Sch\u00fcnemann HJ, Cushman M, Burnett AE et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv 2(22):3198\u20133225. https:\/\/doi.org\/10.1182\/bloodadvances.2018022954","journal-title":"Blood Adv"},{"issue":"2","key":"10422_CR13","doi-asserted-by":"publisher","first-page":"e419S","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C Kearon","year":"2012","unstructured":"Kearon C, Akl EA, Comerota AJ et al (2012) Antithrombotic therapy for VTE disease. Chest 141(2):e419S\u2013e496S. https:\/\/doi.org\/10.1378\/chest.11-2301","journal-title":"Chest"},{"issue":"12","key":"10422_CR14","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMoa1805090","volume":"379","author":"AC Spyropoulos","year":"2018","unstructured":"Spyropoulos AC, Ageno W, Albers GW et al (2018) Rivaroxaban for thromboprophylaxis after hospitalization for medical Illness. N Engl J Med 379(12):1118\u20131127. https:\/\/doi.org\/10.1056\/NEJMoa1805090","journal-title":"N Engl J Med"},{"issue":"6","key":"10422_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1056\/NEJMoa1601747","volume":"375","author":"AT Cohen","year":"2016","unstructured":"Cohen AT, Harrington RA, Goldhaber SZ et al (2016) Extended thromboprophylaxis with betrixaban in acutely ill medical patients. N Engl J Med 375(6):534\u2013544. https:\/\/doi.org\/10.1056\/NEJMoa1601747","journal-title":"N Engl J Med"},{"issue":"6","key":"10422_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1111096","volume":"368","author":"AT Cohen","year":"2013","unstructured":"Cohen AT, Spiro TE, B\u00fcller HR et al (2013) Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 368(6):513\u2013523. https:\/\/doi.org\/10.1056\/NEJMoa1111096","journal-title":"N Engl J Med"},{"issue":"23","key":"10422_CR17","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1110899","volume":"365","author":"SZ Goldhaber","year":"2011","unstructured":"Goldhaber SZ, Leizorovicz A, Kakkar AK et al (2011) Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 365(23):2167\u20132177. https:\/\/doi.org\/10.1056\/NEJMoa1110899","journal-title":"N Engl J Med"},{"issue":"2","key":"10422_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jacc.2019.10.058","volume":"75","author":"CL Fanola","year":"2020","unstructured":"Fanola CL, Norby FL, Shah AM et al (2020) Incident heart failure and long-term risk for venous thromboembolism. J Am Coll Cardiol 75(2):148\u2013158. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.058","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10422_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.amjmed.2010.10.014","volume":"124","author":"G Piazza","year":"2011","unstructured":"Piazza G, Goldhaber SZ, Lessard DM, Goldberg RJ, Emery C, Spencer FA (2011) Venous thromboembolism in heart failure: preventable deaths during and after hospitalization. Am J Med 124(3):252\u2013259. https:\/\/doi.org\/10.1016\/j.amjmed.2010.10.014","journal-title":"Am J Med"},{"issue":"4","key":"10422_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","volume":"20","author":"PL Lutsey","year":"2023","unstructured":"Lutsey PL, Zakai NA (2023) Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol 20(4):248\u2013262. https:\/\/doi.org\/10.1038\/s41569-022-00787-6","journal-title":"Nat Rev Cardiol"},{"key":"10422_CR21","doi-asserted-by":"publisher","unstructured":"Park JH, Ahn SE, Kwon LM et al (2023) The risk of venous thromboembolism in korean patients with breast cancer: a single-center experience. Cancers (Basel) 15(12):3124. Published 2023 Jun 9. https:\/\/doi.org\/10.3390\/cancers15123124","DOI":"10.3390\/cancers15123124"},{"issue":"3","key":"10422_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/jclinpath-2015-203172","volume":"69","author":"E Reichman-Warmusz","year":"2016","unstructured":"Reichman-Warmusz E, Domal-Kwiatkowska D, Matysiak N et al (2016) Tissue factor is unregulated in microvascular endothelial cells of patients with heart failure. J Clin Pathol 69(3):221\u2013225. https:\/\/doi.org\/10.1136\/jclinpath-2015-203172","journal-title":"J Clin Pathol"},{"key":"10422_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.carpath.2018.04.004","volume":"35","author":"IS de Macedo","year":"2018","unstructured":"de Macedo IS, Dinardi LFL, Pereira TV et al (2018) Thromboembolic findings in patients with heart failure at autopsy. Cardiovasc Pathol 35:23\u201328. https:\/\/doi.org\/10.1016\/j.carpath.2018.04.004","journal-title":"Cardiovasc Pathol"},{"issue":"1","key":"10422_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7326\/0003-4819-153-1-201007060-00004","volume":"153","author":"RD Hull","year":"2010","unstructured":"Hull RD, Schellong SM, Tapson VF et al (2010) Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med 153(1):8\u201318. https:\/\/doi.org\/10.7326\/0003-4819-153-1-201007060-00004","journal-title":"Ann Intern Med"},{"issue":"04","key":"10422_CR25","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1055\/a-1926-2489","volume":"06","author":"AC Spyropoulos","year":"2022","unstructured":"Spyropoulos AC, Raskob GE, Spiro TE et al (2022) Extended thromboprophylaxis in hospitalized patients with heart failure: a post hoc analysis of the MAGELLAN study. TH Open 06(04):e304\u2013e308. https:\/\/doi.org\/10.1055\/a-1926-2489","journal-title":"TH Open"},{"key":"10422_CR26","doi-asserted-by":"publisher","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2023) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines [published correction appears in Circulation. 2022 May 3;145(18):e1033] [published correction appears in Circulation. 2022 Sep 27;146(13):e185] [published correction appears in Circulation. Apr 4;147(14):e674]. Circulation. 2022;145(18):e895\u2013e1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","DOI":"10.1161\/CIR.0000000000001063"},{"issue":"36","key":"10422_CR27","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"1","key":"10422_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCHEARTFAILURE.109.892349","volume":"3","author":"TMH Ng","year":"2010","unstructured":"Ng TMH, Tsai F, Khatri N, Barakat MN, Elkayam U (2010) Venous thromboembolism in hospitalized patients with heart failure: incidence, prognosis, and prevention. Circ Heart Fail 3(1):165\u2013173. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.892349","journal-title":"Circ Heart Fail"},{"issue":"6 Suppl","key":"10422_CR29","doi-asserted-by":"publisher","first-page":"381S","DOI":"10.1378\/chest.08-0656","volume":"133","author":"WHq Geerts","year":"2008","unstructured":"Geerts WHq, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):381S\u2013453S. https:\/\/doi.org\/10.1378\/chest.08-0656","journal-title":"Chest"},{"key":"10422_CR30","doi-asserted-by":"publisher","first-page":"107602961988602","DOI":"10.1177\/1076029619886022","volume":"25","author":"AC Spyropoulos","year":"2019","unstructured":"Spyropoulos AC, Lipardi C, Xu J et al (2019) Improved benefit risk profile of rivaroxaban in a subpopulation of the MAGELLAN study. Clin Appl Thromb Hemost 25:1076029619886022. https:\/\/doi.org\/10.1177\/1076029619886022","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"10422_CR31","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1378\/chest.10-1944","volume":"140","author":"AC Spyropoulos","year":"2011","unstructured":"Spyropoulos AC, Anderson FA, FitzGerald G et al (2011) Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140(3):706\u2013714. https:\/\/doi.org\/10.1378\/chest.10-1944","journal-title":"Chest"},{"issue":"11","key":"10422_CR32","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8(11):2450\u20132457. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04044.x","journal-title":"J Thromb Haemost"},{"key":"10422_CR33","doi-asserted-by":"publisher","unstructured":"Schaefer JK, Grant PJ (2023) A need to refine venous thromboembolism risk assessment: the challenge of optimizing patient selection for thromboprophylaxis among hospitalized adults. Res Pract Thromb Haemost 102258. Published online November. https:\/\/doi.org\/10.1016\/j.rpth.2023.102258","DOI":"10.1016\/j.rpth.2023.102258"},{"issue":"6","key":"10422_CR34","doi-asserted-by":"publisher","first-page":"102184","DOI":"10.1016\/j.rpth.2023.102184","volume":"7","author":"B Kocher","year":"2023","unstructured":"Kocher B, Darbellay Farhoumand P, Pulver D et al (2023) Overuse and underuse of thromboprophylaxis in medical inpatients. Res Pract Thromb Haemost 7(6):102184. https:\/\/doi.org\/10.1016\/j.rpth.2023.102184","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10422_CR35","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1055\/s-0037-1603929","volume":"1","author":"CM Gibson","year":"2017","unstructured":"Gibson CM, Spyropoulos AC, Cohen AT et al (2017) The IMPROVEDD VTE risk score: incorporation of D-dimer into the IMPROVE score to improve venous thromboembolism risk stratification. TH Open 1(1):e56\u2013e65. https:\/\/doi.org\/10.1055\/s-0037-1603929","journal-title":"TH Open"},{"issue":"8","key":"10422_CR36","doi-asserted-by":"publisher","first-page":"100597","DOI":"10.1016\/j.jacadv.2023.100597","volume":"2","author":"AC Spyropoulos","year":"2023","unstructured":"Spyropoulos AC, Goldin M, Koulas I et al (2023) Universal EHRs clinical decision support\u00a0for\u00a0thromboprophylaxis in medical\u00a0inpatients: a cluster randomized trial. JACC Adv 2(8):100597. https:\/\/doi.org\/10.1016\/j.jacadv.2023.100597","journal-title":"JACC Adv"},{"issue":"5","key":"10422_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.113.003126","volume":"130","author":"A Mebazaa","year":"2014","unstructured":"Mebazaa A, Spiro TE, B\u00fcller HR et al (2014) Predicting the risk of venous thromboembolism in patients hospitalized with heart failure. Circulation 130(5):410\u2013418. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003126","journal-title":"Circulation"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10422-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-024-10422-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10422-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T08:23:16Z","timestamp":1723018996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-024-10422-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["10422"],"URL":"https:\/\/doi.org\/10.1007\/s10741-024-10422-w","relation":{},"ISSN":["1573-7322"],"issn-type":[{"type":"electronic","value":"1573-7322"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"11 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}